Clinical trials
Recruiting Hyperlipoproteinemia Type II trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abu Dhabi Health Services Company | 1 |
| Atlantic Health System | 1 |
| Brigham and Women's Hospital | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
| Institut de Recherches Cliniques de Montreal | 1 |
| Nantes University Hospital | 1 |
| Odense University Hospital | 1 |
| University of Maryland, Baltimore | 1 |
| University of Wisconsin, Madison | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipoproteinemia Type II | 9 |
| Hypercholesterolemia | 2 |
| Atherosclerosis | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Homozygous Familial Hypercholesterolemia | 1 |
| Hyperlipoproteinemia Type III | 1 |
| Hypoalphalipoproteinemias | 1 |
| Inflammation | 1 |
| Insulin Resistance | 1 |
| Long QT Syndrome | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.